Skip to content
English
  • There are no suggestions because the search field is empty.

Release - Version 3.5

πŸš€ Flinn.ai 3.5 – Smarter Screening, Better Control

This release introduces powerful AI screening rules, more flexible reporting, persistent filters, and expanded monitoring capabilities across Flinn.

  • πŸ€– New: AI Screening Rules Significantly reduce screening effort with AI-recommended exclusions. Use predefined rules for non-human studies, irrelevant study types, case reports, and non-English studies, or create custom screening rules tailored to your search.
  • πŸ“Š Prisma Diagram by Date Range Generate Prisma diagrams for a specific timeframe by selecting a custom date range in the export menu.
  • ⚑ Faster and More Stable Searches Improved performance for large searches, with reduced loading times and fewer errors.
  • πŸ”§ Persistent Filters Your filters and user preferences now stay in place across sessions, so you can return to your work without rebuilding your view.
  • πŸ“‹ Regulatory Monitoring Updates New informative lists, improved evaluation traceability, controlled PDF access, automated license assignment, and expanded source monitoring help teams manage regulatory change with more structure and flexibility.

Enjoy the new release and the smoother workflow across Flinn.

Find the validation documentation here. 

πŸ“š Clinical Literature

πŸ€– New: AI Screening

Significantly reduce screening effort by letting Flinn recommend exclusions for your review workflow. Use both predefined and custom screening rules and review all suggested exclusions in the new review flow.

  • Predefined screening rules for:
    • Non-human studies
    • Irrelevant study types / case reports
    • Non-English studies
  • Custom screening rules:
    • Define your own screening criteria for each search
    • Add additional context or instructions for the AI
  • AI screening works across all data sources. If an abstract is available, screening can be applied.

πŸ“Š Prisma Diagram: Custom Date Range Export

  • Generate a Prisma Diagram directly from the export menu
  • New: Select a custom date range to limit the Prisma chart to a specific timeframe

πŸ›‘οΈ Safety Database Monitoring

πŸ”Ž New Operator: Filter for Adverse Events (MAUDE)

  • Restrict FDA MAUDE results specifically to adverse events
  • Use the new operator in the β€œOther” tab or enter:ADVERSEEVENT:(true)

⚑ Search Performance Improvements

  • Improved search stability and reduced loading times
  • Especially beneficial for searches with large result volumes

🌍 Global Improvements

πŸ”§ UX Improvements: Persistent Filters

  • Filters and user preferences now persist across sessions - your settings remain in place when you log off and back on
  • Switch between views and return to your filtered list without losing your setup

πŸ” Regulatory Monitoring

πŸ“‹ NEW: Informative List

  • Track non-applicable regulations, guidance, and standards for informational purposes - without triggering compliance workflows or notifications
  • Keep a clear separation between actionable and informational documents in your monitoring setup
  • Enable it by contacting our customer solution experts

πŸ“ Evaluation Workflow Improvement

  • Document all evaluation activities in relation to labels and devices directly within Flinn
  • Link evaluations to specific labels and devices for full traceability
  • A single place to track, manage, and review all evaluation work across your normative documents

πŸ“₯ Download PDF

  • Per-organisation control over which normative document sources allow PDF download and print
  • Publicly available sources remain downloadable for all organisations by default
  • Our customer solution experts can enable or disable PDF access per source to match your organisation's licensing agreements

πŸ”‘ Automated License Assignment

  • When enabled, uploading a PDF to a normative document automatically creates and assigns the corresponding license
  • Removes the need for manual license creation - saving time and reducing errors
  • Configurable per organisation and per source

πŸ“‘ Source Monitoring

  • Expanded coverage with additional regulatory source types
  • More reliable and accurate monitoring across global regulatory sources